Eisai Forecasts 73% Leqembi Sales Rise In FY25 As Demand Expands

Primary Care, Blood-Based Biomarkers Key To Growth

 
• By Mandy Jackson
  
Primary care physician outreach is the next frontier in Eisai's Leqembi launch (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Scrip